DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 46 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $640,396 | -12.5% | 52,192 | -14.9% | 0.00% | 0.0% |
| Q2 2023 | $732,053 | +431.9% | 61,311 | +495.6% | 0.00% | – |
| Q1 2023 | $137,631 | -42.1% | 10,294 | -6.9% | 0.00% | – |
| Q4 2022 | $237,882 | +8.6% | 11,054 | +1.1% | 0.00% | – |
| Q3 2022 | $219,000 | +22.3% | 10,929 | +9.5% | 0.00% | – |
| Q2 2022 | $179,000 | +86.5% | 9,985 | +3.1% | 0.00% | – |
| Q1 2022 | $96,000 | -6.8% | 9,687 | +58.6% | 0.00% | – |
| Q4 2021 | $103,000 | -27.0% | 6,106 | +2.5% | 0.00% | – |
| Q3 2021 | $141,000 | – | 5,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |